TABLE 4.
Characteristics of Patients With and Without Subsequent MACE
| No MACE (n = 74) | MACE (n = 63) | p Value | |
|---|---|---|---|
| CMR | |||
| LVEDV, ml | 189 ± 43 | 190 ± 46 | 0.89 |
| LVEDV index, ml/m2 | 96 ± 24 | 100 ± 26 | 0.39 |
| LVESV, ml | 111 ± 43 | 111 ± 41 | 0.96 |
| LVESV index, ml/m2 | 57 ± 22 | 58 ± 23 | 0.65 |
| LVEF, % | 43 ± 13 | 43 ± 11 | 0.98 |
| LV mass, g | 145 ± 46 | 156 ± 50 | 0.18 |
| LV mass index, g/m2 | 76 ± 25 | 79 ± 27 | 0.42 |
| RVEDV, ml | 150 ± 54 | 152 ± 52 | 0.82 |
| RVEDV index, ml/m2 | 75 ± 29 | 79 ± 25 | 0.37 |
| RVESV, ml | 83 ± 41 | 88 ± 45 | 0.46 |
| RVESV index, ml/m2 | 42 ± 21 | 46 ± 21 | 0.23 |
| RVEF, % | 46 ± 11 | 45 ± 12 | 0.62 |
|
| |||
| LGE | 40 (54) | 56 (89) | <0.001 |
| LGE extent (FWHM) | 5.7 ± 2.3 | 12.8 ± 4.2 | <0.001 |
|
| |||
| LGE location | |||
| Subendocardial | 28 (70) | 18 (32) | <0.001 |
| Transmural | 7 (18) | 13 (23) | 0.61 |
| Epicardial | 1 (2) | 7 (13) | 0.13 |
| Mid-myocardial | 4 (8) | 19 (32) | <0.01 |
| Insertion point | 1 (2) | 0 (0) | 0.42 |